RPTX Repare Therapeutics Inc.

16d ago, source: Seeking Alpha

Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic lethality approach in Canada and the United ...

Repare Therapeutics Inc. (RPTX) Soars 8.8%: Is Further Upside Left in the Stock?

2mon ago, source: Hosted on MSN

Repare Therapeutics Inc. (RPTX) shares ended the last trading session 8.8% higher at $8.41. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Repare Therapeutics Inc Ordinary Shares

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Repare Therapeutics to Participate in Two Upcoming Investor Conferences

1mon ago, source: Nasdaq

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)-- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision ...

Buy Rating Affirmed for Repare Therapeutics: Strong Financials and Promising Clinical Catalysts Ahead

1mon ago, source: Business Insider

H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Repare Therapeutics (RPTX – Research Report) today and set a price target of $10.00. Robert Burns has given his Buy rating due to ...

Repare Therapeutics Inc. News

13d ago, source: TheStreet.com

This is not the Bentley for introverts. TheStreet’s automotive reporter got his hands on a Bentley Continental GT V8 S, and he shows off exactly what it can do.

Repare Therapeutics to Regain Global Rights to Camonsertib

1mon ago, source: ADVFN

Repare will regain control of its potential best-in-class oral small molecule ATR inhibitor Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage ...

Repare Therapeutics Inc. (RPTX)

1mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Repare Therapeutics Inc (RPTX)

22d ago, source: Investing

Repare Therapeutics Inc. (NASDAQ:RPTX) announced that its Executive Vice President and Chief Financial Officer, Steve Forte, has recently sold a total of 2,475 company common ...